GW Pharmaceuticals CEO after new drug launch: it’s ‘important to distinguish between what’s medicine and what’s not’ in cannabis

Now, physicians have a level of “assurance” that if they prescribe Epidiolex [GW Pharmaceutical’s CBD], they’re giving patients a federally-sanctioned, standardized form of medication, the CEO said. “We think it’s’ really important to distinguish between what is medicine and what is not.” “They know exactly what is in it, they understand the dosing, they understand its…

READ MORE
Biography/Memoir

A millionaire couple is threatening to create a magic mushroom monopoly

Many of those psilocybin experts now regret having helped the couple [behind Compass Pathways] … Quartz spoke with 9 psilocybin experts who advised Goldsmith and Malievskaia, but today express concerns about the company’s motives and aims … a company that both gains regulatory approval in North America and Europe for medical use of lab-synthesized version of psilocybin and…

READ MORE
Psychology

It’s time to debunk prohibitionist narratives and calls for monopolies within psychedelic science

…exposes a blind spot in the logic of [psychedelic] medicalization. While numerous sanctioned psychedelic researchers tout their belief that psychedelics can “effect true healing,” rather than mere symptomatic treatment, their fixation on the individual as a wholly-bound entity, divorced from their environment, misses the bigger picture. While psychedelics may “effect true healing” of the individual,…

READ MORE
Anthropology

Caves all the way down

There is not one universal psychedelic experience that people from all cultures reliably and predictably have … even with the same substance, different cultures frame psychedelic experiences in different ways, leading to different experiences​​Different cultures, then, create different psychedelic experiences, different ontological realities. But the hope of the psychedelic renaissance is that, by conducting the most…

READ MORE
Medicine/Healing

This is your brain on microdoses of psilocybin

In describing their new study, Prochazkova and co-authors said, “Taken together, our results suggest that consuming a microdose of [psychedelic] truffles allowed participants to create more out-of-the-box alternative solutions for a problem, thus providing preliminary support for the assumption that microdosing improves divergent thinking.”​Although there’s lots of anecdotal evidence about the “mind-expanding” powers of psilocybin,…

READ MORE
Medicine/Healing

Kratom missing from DEA report on drug threats

The Drug Enforcement Administration has released the 2018 National Drug Threat Assessment, the agency’s annual report on drug trafficking and drug abuse in the United States …  there’s not a word about kratom in the National Drug Threat Assessment. There never has been. “It is not surprising.  Kratom is not the ‘dangerous opioid’ that the FDA…

READ MORE
Politics

British injustice : the courts ignore the killers while persecuting the healers

According to the Gosport Independent Panel, between 456 and 650 patients at Gosport Hospital near Portsmouth, UK were deliberately murdered by the National Health Service (NHS) with opioids … Gosport is expected to be the tip of the iceberg.​Nurses first reported the deaths – “an institutionalized practice of shortening lives” – as whistleblowers in 1991. Some…

READ MORE
Politics

Ohio plans to ban kratom…

These studies demonstrate kratom’s potential medical uses. By classifying the active compounds in kratom as Schedule I substances, Ohio’s Board of Pharmacy would prevent further medical research into its benefits (similar to the obstacles the DEA has imposed on research of marijuana, a Schedule I substance).  At the time of the assessment’s release, FDA Commissioner…

READ MORE